Drug Profile
Bisoprolol - Mitsubishi Tanabe Pharma
Alternative Names: Bisoprolol fumarate; Concor; Maintate; TA-4708Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Merck KGaA
- Developer Merck KGaA; Mitsubishi Tanabe Pharma Corporation
- Class Antihypertensives; Heart failure therapies; Ischaemic heart disorder therapies; Propanolamines; Small molecules
- Mechanism of Action Beta 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Angina pectoris; Arrhythmias; Atrial fibrillation; Chronic heart failure; Hypertension
Most Recent Events
- 17 Jun 2013 Launched for Arrhythmias in Japan (PO)
- 17 Jun 2013 Launched for Atrial fibrillation (tachycardiac) in Japan (PO)
- 14 Jun 2013 Registered for Atrial fibrillation (tachycardiac) in Japan (PO)